Keyphrases
Cancer Therapeutics
100%
Breast Cancer Susceptibility Gene 1 (BRCA1)
100%
Binding Site
100%
BRCT Domain
50%
Breast Cancer
33%
Checkpoint Regulation
33%
Small Molecule Inhibitors
33%
DNA Damage
33%
Etoposide
33%
DNA Repair
33%
Specific Intent
33%
Ovarian Cancer
33%
Bleomycin
33%
Breast Cancer Recurrence
16%
Mutant Protein
16%
Cell-based
16%
Cell Behavior
16%
Breast Cancer Patients
16%
Anticancer Agents
16%
DNA Repair Capacity
16%
Growth Inhibition
16%
BACH1
16%
DNA Damage Response
16%
Cell-free
16%
Breast Cancer Cells
16%
Helicase
16%
Successful Completion
16%
Phosphorylated Protein
16%
Apoptosis
16%
Ovarian Tissue
16%
Ovarian Cancer Patients
16%
C-terminus
16%
Amino Acids
16%
Retrospective Clinical Study
16%
Breast Tissue
16%
Tumor
16%
Chemotherapy
16%
Proteinase Inhibitor
16%
Biochemistry, Genetics and Molecular Biology
Binding Site
100%
BRCT Domain
100%
DNA Repair
100%
Bleomycin
66%
Small Molecule
66%
Induced Resistance
33%
Protein-Protein Interaction
33%
Mutant Protein
33%
Helicase
33%
Preclinical Study
33%
Growth Inhibition
33%
Clinical Study
33%
Cancer Cell
33%
BACH1
33%
C-Terminus
33%
Amino Acids
33%
Phosphoprotein
33%
Cell Function
33%
DNA Damage Response
33%
Pharmacology, Toxicology and Pharmaceutical Science
Binding Site
100%
Breast Cancer
100%
Malignant Neoplasm
100%
Ovary Cancer
30%
Bleomycin
20%
Etoposide
20%
Amino Acid
10%
Chemotherapy
10%
Mutant Protein
10%
Acid Protein
10%
Helicase
10%
Clinical Study
10%
Phosphoprotein
10%
Lead Compound
10%
Preclinical Study
10%
Neoplasm
10%
Anticarcinogen
10%